Novo Nordisk launches campaign for injectable weight-loss drug Wegovy

Novo Nordisk, the pharmaceutical company behind Ozempic, has launched a national campaign promoting its injectable weight-loss medication Wegovy.

The Power of Wegovy highlights the individual results of its users while educating consumers on clinical data.

The 90-second hero spot follows a familiar formula for medication advertisements — individuals share what the drug has done for them while doing odd jobs, while a text overlay shows the results of a 68-week study before the commercial veers into potential side effects.